Red Flags Detected

  • Going Concern (new) — Company discloses substantial doubt about ability to continue operations beyond 12 months due to insufficient cash to fund planned operations.
  • Delisting (new) — Received Nasdaq delisting notice in February 2025 for bid price below $1.00 for 30 consecutive days, though subsequently regained compliance.
NASDAQ: ONCY ONCOLYTICS BIOTECH INC 10-K

Oncolytics reports promising cancer trial data but warns of going concern doubt

Filed March 30, 2026 · Period ending December 31, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ONCY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.